This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Humana's pay-for-delay complaint against Bausch, Assertio partially dismissed by US judge

( December 6, 2020, 00:33 GMT | Official Statement) -- MLex Summary: Humana's antitrust complaint against Bausch, Assertio and Lupin, accusing the companies of deliberately delaying the market entry of generic versions of diabetes drug Glumetza, has been partially dismissed by a US judge. Judge William Alsup dismissed the parts of the complaints invoking state law but allowed the federal law claims to continue, ruling that the health insurer failed to show how its subsidiaries acted as indirect purchasers of the drug.Court order is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections